Your browser doesn't support javascript.
Results of a United Kingdom real-world study of polatuzumab vedotin, bendamustine, and rituximab for relapsed/refractory DLBCL.
Northend, Michael; Wilson, William; Osborne, Wendy; Fox, Christopher P; Davies, Andrew J; El-Sharkawi, Dima; Phillips, Elizabeth H; Sim, Hau Wui; Sadullah, Shalal; Shah, Nimish; Peng, Ying Ying; Qureshi, Iman; Addada, Juanah; Mora, Rocio Figueroa; Phillips, Neil; Kuhnl, Andrea; Davies, Elizabeth; Wrench, David; McKay, Pamela; Karpha, Indrani; Cowley, Anna; Karim, Richard; Challenor, Sarah; Singh, Vikram; Burton, Cathy; Auer, Rebecca; Williams, Chris; Cunningham, Joel; Broom, Angus; Arasaretnam, Anita; Roddie, Claire; Menne, Tobias; Townsend, William.
  • Northend M; Department of Haematology, University College Hospital, London, United Kingdom.
  • Wilson W; Haematology Trials Team, Cancer Research United Kingdom & UCL Cancer Trials Centre, London, United Kingdom.
  • Osborne W; Haematology Trials Team, Cancer Research United Kingdom & UCL Cancer Trials Centre, London, United Kingdom.
  • Fox CP; Department of Haematology, Freeman Hospital, The Newcastle-upon-Tyne Hospitals NHS Foundation Trust, Newcastle-upon-Tyne, United Kingdom.
  • Davies AJ; Department of Haematology, Nottingham City Hospital, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom.
  • El-Sharkawi D; Southampton General Hospital, Southampton Cancer Research United Kingdom/National Institute for Health Research Experimental Cancer Medicines Centre, University of Southampton, Southampton, United Kingdom.
  • Phillips EH; Department of Haematology, The Royal Marsden Hospital, Sutton, United Kingdom.
  • Sim HW; Department of Haematology, The Christie Hospital, Manchester, United Kingdom.
  • Sadullah S; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The Christie Hospital, Unit 26, University of Manchester, Manchester, United Kingdom.
  • Shah N; Department of Haematology, Northwick Park Hospital, Middlesex, United Kingdom.
  • Peng YY; Department of Haematology, James Paget University Hospital, Great Yarmouth, United Kingdom.
  • Qureshi I; Department of Haematology, Norfolk & Norwich University Hospital, Norwich, United Kingdom.
  • Addada J; Department of Haematology, St George's Hospital, London, United Kingdom.
  • Mora RF; Department of Haematology, Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom.
  • Phillips N; Department of Haematology, Royal Derby Hospital, University Hospital of Derby & Burton NHS Foundation Trust, Derby, United Kingdom.
  • Kuhnl A; Department of Haematology, Nottingham City Hospital, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom.
  • Davies E; Department of Haematology, Royal Stoke University Hospital, University Hospitals of North Midlands NHS Trust, Stoke-on-Trent, United Kingdom.
  • Wrench D; Department of Haematology, King's College Hospital, King's College Hospital NHS Foundation Trust, London, United Kingdom.
  • McKay P; Department of Haematology, Manchester Royal Infirmary, Manchester University NHS Foundation Trust, Manchester, United Kingdom.
  • Karpha I; Department of Haematology, Guy's Hospital, Guy's & St Thomas' NHS Foundation Trust, London, United Kingdom.
  • Cowley A; Department of Haematology, Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom.
  • Karim R; Department of Haematology, The Clatterbridge Cancer Centre, Wirral, United Kingdom.
  • Challenor S; Department of Haematology, Eastbourne District Hospital, East Sussex Healthcare NHS Trust, Eastbourne, United Kingdom.
  • Singh V; Department of Haematology, Dorset County Hospital, Dorchester, United Kingdom.
  • Burton C; Department of Haematology, Royal Cornwall Hospital, Treliske, United Kingdom.
  • Auer R; Department of Haematology, Aintree University Hospital, Liverpool, United Kingdom.
  • Williams C; Department of Haematology, St James' University Hospital, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom.
  • Cunningham J; Department of Haemato-Oncology, St Bartholomew's Hospital, Bart's Health NHS Trust, London, United Kingdom.
  • Broom A; Department of Haematology, Hexham General Hospital, Northumbria Healthcare NHS Foundation Trust, Hexham, United Kingdom.
  • Arasaretnam A; Department of Haematology, James Paget University Hospital, Great Yarmouth, United Kingdom.
  • Roddie C; Department of Haematology, Western General Hospital, Edinburgh, United Kingdom; and.
  • Menne T; Department of Haematology, Royal Sussex County Hospital, Brighton & Sussex University Hospitals NHS Trust, Brighton, United Kingdom.
  • Townsend W; Department of Haematology, University College Hospital, London, United Kingdom.
Blood Adv ; 6(9): 2920-2926, 2022 05 10.
Article in English | MEDLINE | ID: covidwho-1869039
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Immunoconjugates Language: English Journal: Blood Adv Year: 2022 Document Type: Article Affiliation country: Bloodadvances.2021005953

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Immunoconjugates Language: English Journal: Blood Adv Year: 2022 Document Type: Article Affiliation country: Bloodadvances.2021005953